Obagi reports positive results in testing of acne gel

Long Beach, Calif. - Obagi Medical Products, based here, has released results of a study on its solubilized 5 percent benzoyl peroxide (BPO) gel treatment for acne, Business Wire reports.

The study, which appeared in the June issue of Journal of Drugs in Dermatology, compared results in acne patients treated twice daily with a combination BP/clindamycin antibiotic and patients treated twice daily with 5 percent BPO gel. According to the study, the latter group experienced faster reductions of inflammatory and non-inflammatory lesions at week one, and a significantly greater reduction of inflammatory lesions at week four.

The study noted that both therapies were well-tolerated and showed comparable levels of patient satisfaction.